Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Hyperthermia × Radiotherapy × Clear all

Phase

Phase NA 6 Phase 2 2 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 30 Carcinoma, Non-Small-Cell Lung 30 Lung Neoplasms 23 Head and Neck Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 15 Lymphoma 15 Gliosarcoma 15 Central Nervous System Neoplasms 14 Sarcoma 12 Esophageal Neoplasms 12 Rectal Neoplasms 10 Glioma 10 Leukemia 9 Breast Neoplasms 9 Brain Neoplasms 9 Prostatic Neoplasms 8 Pancreatic Neoplasms 8 Lymphoma, Follicular 7 Esophageal Squamous Cell Carcinoma 7 Neoplasms 6 Melanoma 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Uterine Cervical Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Neoplasm Metastasis 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, B-Cell, Marginal Zone 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Astrocytoma 5

Interventions

Diathermy 2 tislelizumab 1 spartalizumab 1 Radiotherapy 1 Oxaliplatin 1 Immune Checkpoint Inhibitors 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01716949 2017-08-11

HyRec

University of Erlangen-Nürnberg Medical School

Phase 1/2 Unknown

Gastrointestinal

Hyperthermia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡